Literature DB >> 18519587

c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130.

Yoshinori Tanaka1, Nobuyuki Tanaka, Yasushi Saeki, Keiji Tanaka, Masaaki Murakami, Toshio Hirano, Naoto Ishii, Kazuo Sugamura.   

Abstract

Interleukin 6 (IL-6), a pleiotropic cytokine, functions in cells through its interaction with its receptor complex, which consists of two ligand-binding alpha subunits and two signal-transducing subunits known as gp130. There is a wealth of studies on signals mediated by gp130, but its downregulation is less well understood. Here we found that IL-6 stimulation induced lysosome-dependent degradation of gp130, which correlated with an increase in the K63-linked polyubiquitination of gp130. The stimulation-dependent ubiquitination of gp130 was mediated by c-Cbl, an E3 ligase, which was recruited to gp130 in a tyrosine-phosphorylated SHP2-dependent manner. We also found that IL-6 induced a rapid translocation of gp130 from the cell surface to endosomal compartments. Furthermore, the vesicular sorting molecule Hrs contributed to the lysosomal degradation of gp130 by directly recognizing its ubiquitinated form. Deficiency of either Hrs or c-Cbl suppressed gp130 degradation, which leads to a prolonged and amplified IL-6 signal. Thus, our present report provides the first evidence for involvement of a c-Cbl/SHP2 complex in ubiquitination and lysosomal degradation of gp130 upon IL-6 stimulation. The lysosomal degradation of gp130 is critical for cessation of IL-6-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519587      PMCID: PMC2493370          DOI: 10.1128/MCB.01784-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

Review 1.  The Cbl interactome and its functions.

Authors:  Mirko H H Schmidt; Ivan Dikic
Journal:  Nat Rev Mol Cell Biol       Date:  2005-12       Impact factor: 94.444

2.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Authors:  J Schmitz; M Weissenbach; S Haan; P C Heinrich; F Schaper
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.

Authors:  M Scheffner; U Nuber; J M Huibregtse
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

6.  Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.

Authors:  T Yin; T Taga; M L Tsang; K Yasukawa; T Kishimoto; Y C Yang
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.

Authors:  T Ohtani; K Ishihara; T Atsumi; K Nishida; Y Kaneko; T Miyata; S Itoh; M Narimatsu; H Maeda; T Fukada; M Itoh; H Okano; M Hibi; T Hirano
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

8.  The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130.

Authors:  L Terstegen; P Gatsios; J G Bode; F Schaper; P C Heinrich; L Graeve
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

9.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

10.  Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.

Authors:  D Pennica; K J Shaw; T A Swanson; M W Moore; D L Shelton; K A Zioncheck; A Rosenthal; T Taga; N F Paoni; W I Wood
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

View more
  41 in total

1.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

2.  Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor.

Authors:  Gamze Betul Bulut; Rita Sulahian; Yue Ma; Nai-wen Chi; Lily Jun-shen Huang
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

3.  Targeting F box protein Fbxo3 to control cytokine-driven inflammation.

Authors:  Rama K Mallampalli; Tiffany A Coon; Jennifer R Glasser; Claire Wang; Sarah R Dunn; Nathaniel M Weathington; Jing Zhao; Chunbin Zou; Yutong Zhao; Bill B Chen
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

4.  The proinflammatory role of HECTD2 in innate immunity and experimental lung injury.

Authors:  Tiffany A Coon; Alison C McKelvey; Travis Lear; Shristi Rajbhandari; Sarah R Dunn; William Connelly; Joe Y Zhao; SeungHye Han; Yuan Liu; Nathaniel M Weathington; Bryan J McVerry; Yingze Zhang; Bill B Chen
Journal:  Sci Transl Med       Date:  2015-07-08       Impact factor: 17.956

Review 5.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

6.  Janus Kinase 2 Inhibitor AG490 Inhibits the STAT3 Signaling Pathway by Suppressing Protein Translation of gp130.

Authors:  In Ae Seo; Hyun Kyoung Lee; Yoon Kyung Shin; Sang Hwa Lee; Su-Yeong Seo; Ji Wook Park; Hwan Tae Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

7.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

8.  Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorder.

Authors:  Monica Uddin; Andrew Ratanatharathorn; Don Armstrong; Pei-Fen Kuan; Allison E Aiello; Evelyn J Bromet; Sandro Galea; Karestan C Koenen; Benjamin Luft; Kerry J Ressler; Derek E Wildman; Caroline M Nievergelt; Alicia Smith
Journal:  Epigenomics       Date:  2018-11-20       Impact factor: 4.778

9.  Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.

Authors:  Sutapa Ray; Yingxin Zhao; Mohammad Jamaluddin; Chukwudi B Edeh; Chang Lee; Allan R Brasier
Journal:  Cell Signal       Date:  2014-03-20       Impact factor: 4.315

10.  Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.

Authors:  Sebastian J Saur; Veena Sangkhae; Amy E Geddis; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.